Logo image of SBIG

SPRINGBIG HOLDINGS INC (SBIG) Stock Fundamental Analysis

NASDAQ:SBIG - Nasdaq - US85021Q1085 - Common Stock - Currency: USD

0.1912  -0.04 (-16.83%)

After market: 0.145 -0.05 (-24.16%)

Fundamental Rating

2

SBIG gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 282 industry peers in the Software industry. Both the profitability and financial health of SBIG have multiple concerns. SBIG is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

SBIG had negative earnings in the past year.
SBIG had a negative operating cash flow in the past year.
SBIG Yearly Net Income VS EBIT VS OCF VS FCFSBIG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 -5M -10M -15M

1.2 Ratios

SBIG has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SBIG Yearly ROA, ROE, ROICSBIG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 0 2K 4K 6K 8K

1.3 Margins

The Gross Margin of SBIG (77.36%) is better than 75.72% of its industry peers.
The Profit Margin and Operating Margin are not available for SBIG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 77.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SBIG Yearly Profit, Operating, Gross MarginsSBIG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 0 20 -20 40 -40 60 -60

0

2. Health

2.1 Basic Checks

SBIG does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SBIG has more shares outstanding
SBIG has a worse debt/assets ratio than last year.
SBIG Yearly Shares OutstandingSBIG Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 5M 10M 15M 20M 25M
SBIG Yearly Total Debt VS Total AssetsSBIG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2M 4M 6M 8M 10M

2.2 Solvency

SBIG has an Altman-Z score of -7.93. This is a bad value and indicates that SBIG is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -7.93, SBIG is not doing good in the industry: 89.13% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -7.93
ROIC/WACCN/A
WACC10.17%
SBIG Yearly LT Debt VS Equity VS FCFSBIG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 0 5M -5M -10M

2.3 Liquidity

SBIG has a Current Ratio of 0.60. This is a bad value and indicates that SBIG is not financially healthy enough and could expect problems in meeting its short term obligations.
SBIG's Current ratio of 0.60 is on the low side compared to the rest of the industry. SBIG is outperformed by 89.49% of its industry peers.
SBIG has a Quick Ratio of 0.60. This is a bad value and indicates that SBIG is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of SBIG (0.60) is worse than 89.13% of its industry peers.
Industry RankSector Rank
Current Ratio 0.6
Quick Ratio 0.6
SBIG Yearly Current Assets VS Current LiabilitesSBIG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2M 4M 6M 8M 10M

4

3. Growth

3.1 Past

The earnings per share for SBIG have decreased strongly by -1209.72% in the last year.
The Revenue has grown by 330.89% in the past year. This is a very strong growth!
EPS 1Y (TTM)-1209.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.22%
Revenue 1Y (TTM)330.89%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%12.46%

3.2 Future

Based on estimates for the next years, SBIG will show a very strong growth in Earnings Per Share. The EPS will grow by 26.96% on average per year.
SBIG is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 38.51% yearly.
EPS Next Y69.76%
EPS Next 2Y42.15%
EPS Next 3Y28.75%
EPS Next 5Y26.96%
Revenue Next Year13.11%
Revenue Next 2Y19.24%
Revenue Next 3Y24.6%
Revenue Next 5Y38.51%

3.3 Evolution

SBIG Yearly Revenue VS EstimatesSBIG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
SBIG Yearly EPS VS EstimatesSBIG Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 0 0.2 -0.2 -0.4

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SBIG. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 18.75, SBIG is valued on the expensive side.
Based on the Price/Forward Earnings ratio, SBIG is valued cheaply inside the industry as 83.70% of the companies are valued more expensively.
SBIG's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 21.70.
Industry RankSector Rank
PE N/A
Fwd PE 18.75
SBIG Price Earnings VS Forward Price EarningsSBIG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SBIG Per share dataSBIG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 0.6

4.3 Compensation for Growth

SBIG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SBIG's earnings are expected to grow with 28.75% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.15%
EPS Next 3Y28.75%

0

5. Dividend

5.1 Amount

SBIG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SPRINGBIG HOLDINGS INC

NASDAQ:SBIG (9/1/2023, 8:00:02 PM)

After market: 0.145 -0.05 (-24.16%)

0.1912

-0.04 (-16.83%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-10 2023-08-10/amc
Earnings (Next)N/A N/A
Inst Owners0.08%
Inst Owner Change0%
Ins Owners19.65%
Ins Owner Change0%
Market Cap7.95M
Analysts84.44
Price Target1.43 (647.91%)
Short Float %0%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-50.9%
Min EPS beat(2)-56.86%
Max EPS beat(2)-44.93%
EPS beat(4)2
Avg EPS beat(4)-10.17%
Min EPS beat(4)-56.86%
Max EPS beat(4)34.64%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-10.65%
Min Revenue beat(2)-18.08%
Max Revenue beat(2)-3.22%
Revenue beat(4)1
Avg Revenue beat(4)-6.81%
Min Revenue beat(4)-18.08%
Max Revenue beat(4)4.43%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.67%
PT rev (3m)-13.4%
EPS NQ rev (1m)0%
EPS NQ rev (3m)18.51%
EPS NY rev (1m)0%
EPS NY rev (3m)-8.64%
Revenue NQ rev (1m)-1.33%
Revenue NQ rev (3m)-3.9%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.1%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 18.75
P/S 0.29
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.51
EYN/A
EPS(NY)0.01
Fwd EY5.33%
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS0.66
BVpS-0.14
TBVpS-0.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 77.36%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover3.31
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.6
Quick Ratio 0.6
Altman-Z -7.93
F-Score2
WACC10.17%
ROIC/WACCN/A
Cap/Depr(3y)410.48%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.97%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1209.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.22%
EPS Next Y69.76%
EPS Next 2Y42.15%
EPS Next 3Y28.75%
EPS Next 5Y26.96%
Revenue 1Y (TTM)330.89%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%12.46%
Revenue Next Year13.11%
Revenue Next 2Y19.24%
Revenue Next 3Y24.6%
Revenue Next 5Y38.51%
EBIT growth 1Y-224.79%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year85.33%
EBIT Next 3Y33.01%
EBIT Next 5Y32.04%
FCF growth 1Y-80.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-84.15%
OCF growth 3YN/A
OCF growth 5YN/A